University of California (Irvine) Hematology and Medical Oncology

Fellowship · Orange, CA

Sponsored by University of California (Irvine) · Director Jason Zell

Jason Zell, DO, MPH
Program Director
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Cancer Prevention, Colorectal Cancer, Gastrointestinal Oncology, Genetic Epidemiology
Catherine Coombs, MD, MS
Associate Program Director
Hematologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Androgen Receptor Antagonists, Antineoplastic Combined Chemotherapy Protocols, Bridged Bicyclo Compounds, Heterocyclic, Hematopoiesis
Angela Fleischman, MD, PhD
Research Rotation Director
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Hematologic malignancies, Hematopoiesis, Myeloproliferative neoplasm
Ann Eapen, MD
Associate Program Director and LBVA Site Director
Internist, Assistant Professor — Division of Hematology and Oncology at UC Irvine School of Medicine
Hematology/Oncology
Miguel Villalona-Calero, MD
Division Chief
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)
Genomic driven therapy, Lung cancer and developmental therapeutics, designing new and more effective anticancer agents, Novel ways to use the immune system to target cancer
Alex Minella, MD
Faculty
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
acute leukemia, cell and gene therapy, cell cycle regulation, hematologic malignancies
Andreea Nanci, MD, MBA
Faculty
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)
April Choi, MD
Faculty
Hematologist, Assistant Professor — Division of Hematology and Oncology at University of California (Irvine)
Arash Kalebasty, MD
Faculty · Papers with 2 fellows since 2023
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Bladder, immunotherapy and targeted therapies for cancers of the prostate, Kidney and testes
Argyrios Ziogas, PhD
Faculty
Adjunct Professor — General Internal Medicine and Primary Care at University of California (Irvine)
Biostatistics, Epidemiology, Statistical Genetics
Blake Adnani, MD
Third Year, Inferred 2026-2027
Internal Medicine resident, University of Southern California/Los Angeles General Medical Center (USC/LA General)
Brian Warnecke, MD, DO
Instructing Faculty
Oncologist, Instructing Faculty at UC Irvine
Carmen Say, MD
Second Year, Inferred 2026-2027
Internal Medicine resident, University of Southern California/Los Angeles General Medical Center (USC/LA General)
Cathleen Park, MD
Faculty
Oncologist, Assistant Professor — Division of Hematology & Oncology at University of California (Irvine)
Daesik Kim
Faculty
Visiting Associate Professor at University of California (Irvine)
Dalia Kaakour, MD
Hematology and Medical Oncology Fellow · Hematology and Medical Oncology Fellowship
Hematology and Medical Oncology fellow, University of California (Irvine)
Deepa Jeyakumar, MD
Faculty
Hematologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Leukemias, Lymphomas, Myelodysplastic syndrome
Donovan Argueta, PhD
Faculty
Assistant Professor — Division of Hematology and Oncology at University of California (Irvine)
Analgesics, Anemia, Sickle Cell, Anti-Inflammatory Agents, beta-Endorphin
Dusit Jit-ueakul, MD
Faculty
Oncologist, Visiting Assistant Professor — Division of Hematology & Oncology at University of California (Irvine)
Adult, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Humans
Edward Nelson, MD
Faculty
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)
Elizabeth Brem, MD
Faculty
Hematologist, Assistant Professor — Division of Hematology and Oncology at University of California (Irvine)
Apoptosis, Bcl2 family, Lymphoma
Emad Elquza, MD
Faculty
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Cartilage Oligomeric Matrix Protein, Chemoradiotherapy
Erin Alexis, MD
Faculty
Oncologist, Assistant Clinical Professor — Division of Hematology & Oncology at University of California (Irvine)
Antibodies, Bispecific, Antigens, CD19, Biological Products, Ciprofloxacin
Fa Lee, MD
Faculty
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)

Jason Zell, DO, MPH
Program Director
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Cancer Prevention, Colorectal Cancer, Gastrointestinal Oncology, Genetic Epidemiology
Catherine Coombs, MD, MS
Associate Program Director
Hematologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Androgen Receptor Antagonists, Antineoplastic Combined Chemotherapy Protocols, Bridged Bicyclo Compounds, Heterocyclic, Hematopoiesis
Angela Fleischman, MD, PhD
Research Rotation Director
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Hematologic malignancies, Hematopoiesis, Myeloproliferative neoplasm
Ann Eapen, MD
Associate Program Director and LBVA Site Director
Internist, Assistant Professor — Division of Hematology and Oncology at UC Irvine School of Medicine
Hematology/Oncology
Miguel Villalona-Calero, MD
Division Chief
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)
Genomic driven therapy, Lung cancer and developmental therapeutics, designing new and more effective anticancer agents, Novel ways to use the immune system to target cancer
Alex Minella, MD
Faculty
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
acute leukemia, cell and gene therapy, cell cycle regulation, hematologic malignancies
Andreea Nanci, MD, MBA
Faculty
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)
April Choi, MD
Faculty
Hematologist, Assistant Professor — Division of Hematology and Oncology at University of California (Irvine)
Arash Kalebasty, MD
Faculty · Papers with 2 fellows since 2023
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Bladder, immunotherapy and targeted therapies for cancers of the prostate, Kidney and testes
Argyrios Ziogas, PhD
Faculty
Adjunct Professor — General Internal Medicine and Primary Care at University of California (Irvine)
Biostatistics, Epidemiology, Statistical Genetics
Blake Adnani, MD
Third Year, Inferred 2026-2027
Internal Medicine resident, University of Southern California/Los Angeles General Medical Center (USC/LA General)
Brian Warnecke, MD, DO
Instructing Faculty
Oncologist, Instructing Faculty at UC Irvine
Carmen Say, MD
Second Year, Inferred 2026-2027
Internal Medicine resident, University of Southern California/Los Angeles General Medical Center (USC/LA General)
Cathleen Park, MD
Faculty
Oncologist, Assistant Professor — Division of Hematology & Oncology at University of California (Irvine)
Daesik Kim
Faculty
Visiting Associate Professor at University of California (Irvine)
Dalia Kaakour, MD
Hematology and Medical Oncology Fellow · Hematology and Medical Oncology Fellowship
Hematology and Medical Oncology fellow, University of California (Irvine)
Deepa Jeyakumar, MD
Faculty
Hematologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Leukemias, Lymphomas, Myelodysplastic syndrome
Donovan Argueta, PhD
Faculty
Assistant Professor — Division of Hematology and Oncology at University of California (Irvine)
Analgesics, Anemia, Sickle Cell, Anti-Inflammatory Agents, beta-Endorphin
Dusit Jit-ueakul, MD
Faculty
Oncologist, Visiting Assistant Professor — Division of Hematology & Oncology at University of California (Irvine)
Adult, Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Humans
Edward Nelson, MD
Faculty
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)
Elizabeth Brem, MD
Faculty
Hematologist, Assistant Professor — Division of Hematology and Oncology at University of California (Irvine)
Apoptosis, Bcl2 family, Lymphoma
Emad Elquza, MD
Faculty
Oncologist, Associate Professor — Division of Hematology and Oncology at University of California (Irvine)
Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Cartilage Oligomeric Matrix Protein, Chemoradiotherapy
Erin Alexis, MD
Faculty
Oncologist, Assistant Clinical Professor — Division of Hematology & Oncology at University of California (Irvine)
Antibodies, Bispecific, Antigens, CD19, Biological Products, Ciprofloxacin
Fa Lee, MD
Faculty
Oncologist, Professor — Division of Hematology and Oncology at University of California (Irvine)